Earnings Summary: Highlights of Organon’s Q2 2023 results 3 years ago Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter… Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights 3 years ago Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim… Four factors that do not work in favor of Beyond Meat (BYND) 3 years ago Shares of Beyond Meat, Inc. (NASDAQ: BYND) stayed red on Wednesday. The stock has dropped 64% over the past 12… Earnings Summary: Jacobs Solutions reports higher Q3 2023 revenues 3 years ago Jacobs Solutions Inc. (NYSE: J), a leading provider of technical professional services, reported an increase in third-quarter revenues. The company… Earnings Summary: A snapshot of Expeditors International’s Q2 results 3 years ago Expeditors International of Washington, Inc. (NASDAQ: EXPD) announced financial results for the second quarter of 2023. The logistics company said… Walt Disney Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript 3 years ago Entertainment giant The Walt Disney Company (NYSE: DIS) will be reporting operating results for the third quarter of 2023 today… Earnings Summary: Charles River Laboratories reports Q2 2023 results 3 years ago Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.… Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary 3 years ago Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the… Twilio (TWLO) Earnings: 2Q23 Key Numbers 3 years ago Twilio (NYSE: TWLO) reported total revenue of $1.04 billion for the second quarter of 2023, which was up 10% year-over-year.… Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs 3 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and… Next» « Previous